Αποτελέσματα Αναζήτησης
31 Μαΐ 2023 · Tracheomalacia (TM) refers to weakness in the airway wall, resulting in excessive airway narrowing during expiration. The treatment and prognosis of TM in adults are reviewed here. Clinical presentation and diagnosis of TM and TM in children are discussed separately.
- Tracheomalacia in adults: Clinical features and diagnostic ... - UpToDate
Tracheomalacia (TM) refers to weakness in the airway wall...
- Tracheomalacia in adults: Clinical features and diagnostic ... - UpToDate
29 Ιουλ 2024 · Tracheomalacia (TM) refers to weakness in the airway wall resulting in excessive airway narrowing during expiration. The epidemiology, clinical manifestations, and diagnosis of TM in adults are reviewed here. Treatment of TM and TM in children are discussed separately.
26 Ιουν 2023 · Prognosis. For patients with congenital disease and mild symptoms, the prognosis is generally favorable, and symptoms tend to resolve by around the age of 2 years. Patients with other co-existing comorbidities tend to have persistent symptoms until later in childhood.
2 Ιουλ 2013 · Severe adult tracheomalacia is a dangerous disease that is difficult to manage, particularly at the time of airway infection, and has a high mortality rate. The present study reports the diagnosis and treatment of an elderly patient with severe adult tracheomalacia.
23 Οκτ 2024 · Tracheomalacia (TRAY-kee-oh-muh-LAY-shia) is when you have weak or floppy cartilage in your trachea (windpipe). The walls of your windpipe can collapse or fall in, causing symptoms like high-pitched breathing. It can also trap mucus in your lungs, making it difficult to clear them out.
Treatment Outcome. Severe, diffuse tracheobronchomalacia (TBM) is an underrecognized cause of dyspnea, recurrent respiratory infections, cough, secretion retention, and even respiratory insufficiency.
21 Νοε 2023 · This atypical presentation highlights the complexity of TM in adults. It underscores the importance of considering it as a differential diagnosis, particularly in male smokers with gradual, persistent dyspnea and a minimal history of pulmonary disease.
